FDA approval opens new chapter in pancreatic cancer treatment

For decades, a diagnosis of metastatic pancreatic cancer left patients and physicians facing the same harsh reality: limited options, difficult treatments and too little time. Now, a pill tested in a global clinical trial ...

Altered ribosomes help explain how an enzyme fuels tumor growth

A new Northwestern Medicine study has identified a previously unknown mechanism by which an enzyme promotes cancer cell proliferation, establishing it as a promising therapeutic target for cancer, according to findings published ...

page 3 from 40